Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP2139 |
AMY-101
Cp40 |
Others | Others |
AMY-101 is a peptidic inhibitor of the central complement component C3 (KD: 0.5 nM). AMY-101 shows a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation. | |||
TP2139L |
AMY-101 TFA
Cp40 TFA |
Others | Others |
AMY-101 TFA (Cp40 TFA) is a peptidic inhibitor of the central complement component C3 (KD: 0.5 nM). AMY-101 TFA shows a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation. |